Abstract
Objectives
The synovial membrane and fluid are involved in the pathogenesis of temporomandibular joint (TMJ) disorders. This study aims to assess the relationship between matrix metalloproteinase-2 (MMP-2), chemerin and prostaglandin (PGE2) levels in the synovial fluid (SF) and saliva of patients with TMJ disorder regarding their role in inflammation and the value of being a candidate for predictive biomarkers in the disease. Also, it is aimed to find out whether chemerin’s main function triggers the formation inflammatory cytokine markers in the associated area.
Materials and methods
Thirty-two samples of SF and saliva were obtained from patients with disc displacement without reduction with limited opening (DDWORwLO). Mann-Whitney-U test was used for the comparisons of the biomarker levels in SF and saliva. The correlation between chemerin and BMI (Body Mass Index) is analyzed by non-parametric Spearman’s rho correlation coefficient.
Results
For all of the three biomarkers, statistically significant differences were found between SF and saliva. An unexpectedly high level expression of chemerin was observed in SF. A statistically significant, positive correlation was observed between PGE2 -MMP-2, and chemerin-PGE2 in saliva, chemerin and MMP-2 in SF, respectively (p = 0.031, r = 0.382 / p = 0.039, r = 0.366 / p = 0.032, r = 0.379). A positive correlation was determined between saliva and SF levels of PGE2 (p = 0.016, r = 0.421).
Conclusions
Chemerin, MMP-2, and PGE2 can play a role as an inflammatory factor for the development of TMJ disorder.
Clinical relevance
The search for molecular markers in TMJ and the inhibition of the associated molecular signaling mechanism is important to reduce joint inflammation and cartilage degradation.
Similar content being viewed by others
References
McNeill C (1997) Management of temporomandibular disorders: concepts and controversies. J Prosthet Dent 77:510–522
Mizui T, Ishimaru JI, Miyamoto K, Kurita K (2001) Matrix metalloproteinase-2 in synovial lavage fluid of patients with disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 39:310–314
Maroudas A (1976) Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 260:808–809
Ghadially FN (1981) Structure and function of articular-cartilage. Clin Rheum Dis 7:3–28
Kubota E, Imamura H, Kubota T, Shibata T, Murakami KI (1997) Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55:20–27
Zardeneta G, Milan SB, Lee T, Schmits JP (1998) Detection and preliminary characterization of matrix metalloproteinase activity in temporomandibular joint lavage fluid. J Oral Maxillofac Surg 27:397–403
Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125
Brinckerhoff CE (1991) Joint destruction in arthritis: Metalloproteinases the spotlight. Arthritis Rheumatol 34:1073–1075
Attur M, Krasnokutsky-Samuels S, Samuels J, Abramson SB (2013) Prognostic biomarkers in osteoarthritis. Curr Opin Rheumatol 25:136–144
Vos LM, Kuijer R, Huddleston Slater JJ, Bulstra SK, Stegenga B (2014) Inflammation is more distinct in temporomandibular joint osteoarthritis compared to the knee joint. J Oral Maxillofac Surg 72:35–40
Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M (2002) Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:328–332
Ernberg M (2017) The role of molecular pain biomarkers in temporomandibular joint internal derangement. J Oral Rehabil 44:481–491
Sorsa T, Tjaderhane L, Salo T (2004) Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10:311–318
Buisson-Legendre N, Smith S, March L, Jackson C (2004) Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2. Arthritis Rheumatol 50:2151–2156
Puliti M, Momi S, Falcinelli E, Gresele P, Fetal B (2012) Contribution of matrix metalloproteinase 2 to joint destruction in group B streptococcus-induced murine arthritis. Arthritis Rheumatol 64:1089–1097
Kaur J, Adya R, Tan BK, Chen J, Randeva HS (2010) Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin induced endothelial angiogenesis. Biochem Biophys Res Commun 391:1762–1768
Muruganandan S, Parlee SD, Rourke JL, Ernst MC, Goralski KB, Sinal CJ (2011) Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPAR gamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem 286:23982–23995
Ernst MC, Issa M, Goralski KB, Sinal CJ (2010) Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151:1998–2007
Jin CH, Yi KW, Ha YR, Shin JH, Park HT, Kim T, Hur JY (2015) Chemerin expression in the peritoneal fluid, serum, and ovarian endometrioma of women with endometriosis. Am J Reprod Immunol 74:379–386
Patnaik K, Pradeep AR, Nagpal K, Karvekar S, Singh P, Raju A (2017) Human chemerin correlation in gingival crevicular fluid and tear fluid as markers of inflammation in chronic periodontitis and type-2 diabetes mellitus. J Investig Clin Dent 8:12181–12188
Eisinger K, Bauer S, Schaffler A, Walter R, Neumann E, Buechler C, Müller- Ladner U, Frommer KW (2012) Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp Mol Patho 92:90–96
Berg V, Sveinbjörnsson B, Bendiksen S, Brox J, Meknas K, Figenschau Y (2010) Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin 21-157. Arthritis Res Ther 12:228
Conde J, Gomez R, Bianco G, Scotece M, Lear P, Dieguez C, Gomez-Reino J, Lago F, Gualillo O (2011) Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis 70:551–559
Verma RP, Hansch C (2007) Matrix metalloproteinases (MMPs): chemical-biological functions and (Q) SARs. Bioorg Med Chem 15:2223–2268
Yan W, Apweiler R, Balgley BM, Boontheung P, Bundy JL, Cargile BJ, Cole S, Fang X, Gonzalez-Begne M, Griffin TJ (2009) Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl 3:116–134
Shoukri B, Prieto JC, Ruellas A, Yatabe M, Sugai J, Styner M, Zhu H, Huang C, Paniagua B, Aronovich S, Ashman L, Benavides E, de Dumast P, Ribera NT, Mirabel C, Michoud L, Allohaibi Z, Loshida M, Bittencourt L, Fattori L, Gomes LR, Cevidanes L (2019) Minimally invasive approach for diagnosing TMJ osteoarthritis. J Dent Res 98:1103–1111
Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, Ferro JM, Oliveira SA, Vicente AM (2010) Variants of the matrix Metalloproteinase-2 but not the matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 11:40
Milward EA, Kim KJ, Szklarczyk A, Nguyen T, Melli G, Nayak M, Deshpande D, Fitzsimmons C, Hoke A, Kerr D, Griffin JW, Calabresi PA, Conant K (2008) Cleavage of myelin associated glycoprotein by matrix metalloproteinase. J Neuroimmunol 193:140–148
Bobińska K, Szemraj J, Czarny P, Gałecki P (2016) Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder. J Affect Disord 205:119–129
Rafni E, Yanwirasti Y, Darwin E, Rikmasari R (2017) The difference of matrix metalloproteinase-9 level in saliva between myofascial pain and disc displacement of temporomandibular joint disorders. Padjadjaran Journal of Dentistry 29
Ma J, Niu DS, Wan NJ, Qin Y, Guo CJ (2015) Elevated chemerin levels in synovial fluid and synovial membrane from patients with knee osteoarthritis. Int J Clin Exp Pathol 8:13393–13398
Bas S, Finckh A, Puskas GJ, Suva D, Hoffmeyer P, Gabay C, Lübbeke A (2014) Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. Int Orthop 38:2577–2583
Huang K, Du G, Li L, Liang H, Zhang B (2012) Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis. Biomarkers 17(1):16–20
Ku JH, Lee CK, Joo BS, An BM, Choi SH, Wang TH, Cho HL (2009) Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis. J Clin Rheumatol 28:1431–1435
Karvonen-Gutierrez CA, Harlow SD, Mancuso P, Jacobson J, Mendes de Leon CF, Nan B (2013) Association of leptin levels with radiographic knee osteoarthritis among a cohort of midlife women. Arthritis Care Res 65:936–944
Pfau D, Bachmann A, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M (2010) Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 33:171–173
Jentsch HFR, Arnold N, Richter V, Deschner J, Kantyka T, Eick S (2017) Salivary, gingival crevicular fluid and serum levels of ghrelin and chemerin in patients with periodontitis and overweight. J Periodontal Res 52:1050–1057
Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, Pedersen AA, Kalthoff C, Tullin S, Sams A, Summer R, Walsh K (2010) Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 285:6153–6160
Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brezillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198:977–985
Güven O, Tekin U, Salmanoğlu B, Kaymak E (2015) Tumor necrosis factor- alpha levels in the synovial fluid of patients with temporomandibular joint internal derangement. J Craniomaxillofac Surg 43:102–105
Acknowledgments
We thank Karadag O. (Department of Statistics, Graduate School of Science and Engineering, Hacettepe University) and Tasdelen B. (Department of Biostatistics and Medical Informatics, Mersin University) for their great efforts for the statistical analysis.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants (parents) included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yaman, D., Alpaslan, C., Akca, G. et al. Correlation of molecular biomarker concentrations between synovial fluid and saliva of the patients with temporomandibular disorders. Clin Oral Invest 24, 4455–4461 (2020). https://doi.org/10.1007/s00784-020-03310-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-020-03310-8